Agilent, Applied Spectral Imaging Enter FISH Marketing Agreement
Agilent Technologies Inc. and Applied Spectral Imaging (ASI) Inc. have entered into a marketing agreement for ASI’s GenASIs imaging platforms and Agilent’s fluorescence in situ hybridization (FISH) products.
“Difficulty of fluorescence-based molecular analysis has always been a major pain point for our customers,” said Herman Verrelst, vice president and general manager of Agilent’s genomics solutions and clinical applications divisions.
The agreement includes the marketing of Agilent’s Dako Omnis instrument for automated FISH sample processing.
ASI is a developer of imaging solutions for fluorescent, bright-field and spectral image acquisition in karyotyping, FISH and other pathology tests. Agilent provides instruments for the life sciences, diagnostics and applied chemical markets.
LATEST NEWS
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024
- One-Step Hologram Generation Speeds 3D Display Creation
Apr 24, 2024
- Innovation Award Winners for Laser Technology Honored in Aachen
Apr 23, 2024
- Intech 2024: AI Arrives on the Shop Floor
Apr 22, 2024